Detailed information for compound 1690648

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 549.123 | Formula: C31H33ClN2O3S
  • H donors: 0 H acceptors: 1 LogP: 7.8 Rotable bonds: 11
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCCCc1sc(nc1c1ccc(cc1)Oc1ccc(cc1)Cl)c1ccc(cc1)OCCN1CCOCC1
  • InChi: 1S/C31H33ClN2O3S/c1-2-3-4-29-30(23-5-13-27(14-6-23)37-28-15-9-25(32)10-16-28)33-31(38-29)24-7-11-26(12-8-24)36-22-19-34-17-20-35-21-18-34/h5-16H,2-4,17-22H2,1H3
  • InChiKey: HMNSBKFTIMZTNM-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0023 0.8323 0.8001
Trypanosoma cruzi PAB1-binding protein , putative 0.0025 1 0.5
Entamoeba histolytica acyl-CoA synthetase, putative 0.0023 0.8323 0.5
Onchocerca volvulus 0.0023 0.8323 0.5
Chlamydia trachomatis acylglycerophosphoethanolamine acyltransferase 0.0018 0.1614 0.5
Mycobacterium ulcerans long-chain-fatty-acid--CoA ligase 0.0023 0.8323 1
Mycobacterium ulcerans acyl-CoA synthetase 0.0023 0.8323 1
Mycobacterium tuberculosis Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) 0.0018 0.1614 0.139
Mycobacterium leprae PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) 0.0023 0.8323 0.5
Toxoplasma gondii LsmAD domain-containing protein 0.0025 1 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.0025 1 0.5
Mycobacterium ulcerans acyl-CoA synthetase 0.0023 0.8323 1
Brugia malayi AMP-binding enzyme family protein 0.0023 0.8323 0.8323
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0023 0.8323 1
Plasmodium falciparum ataxin-2 like protein, putative 0.0025 1 1
Entamoeba histolytica acyl-coA synthetase, putative 0.0023 0.8323 0.5
Plasmodium falciparum ataxin-2 like protein, putative 0.0025 1 1
Brugia malayi AMP-binding enzyme family protein 0.0023 0.8323 0.8323
Mycobacterium tuberculosis Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) 0.0023 0.8323 1
Loa Loa (eye worm) hypothetical protein 0.0025 1 1
Brugia malayi AMP-binding enzyme family protein 0.0023 0.8323 0.8323
Loa Loa (eye worm) hypothetical protein 0.0023 0.8323 0.8001
Mycobacterium leprae PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) 0.0023 0.8323 0.5
Mycobacterium ulcerans hypothetical protein 0.0023 0.8323 1
Entamoeba histolytica acyl-CoA synthetase, putative 0.0023 0.8323 0.5
Mycobacterium ulcerans fatty-acid-CoA ligase 0.0023 0.8323 1
Trypanosoma brucei PAB1-binding protein , putative 0.0025 1 0.5
Mycobacterium ulcerans acyl-CoA synthetase 0.0023 0.8323 1
Mycobacterium ulcerans long-chain-fatty-acid-CoA ligase 0.0023 0.8323 1
Leishmania major hypothetical protein, conserved 0.0025 1 1
Plasmodium vivax ataxin-2 like protein, putative 0.0025 1 1
Mycobacterium ulcerans long-chain fatty-acid CoA ligase 0.0023 0.8323 1
Loa Loa (eye worm) hypothetical protein 0.0023 0.8323 0.8001

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 22.9 % Antagonist activity at human biotinylated RAGE assessed as inhibition of amyloid beta binding at 10 uM after 60 mins by ELISA ChEMBL. 23140885

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.